These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9145 related articles for article (PubMed ID: 11530496)

  • 1. [Exosomes derived from dendritic cells].
    Amigorena S
    J Soc Biol; 2001; 195(1):25-7. PubMed ID: 11530496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy using dendritic cell-derived exosomes.
    Amigorena S
    Medicina (B Aires); 2000; 60 Suppl 2():51-4. PubMed ID: 11188932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ; O'Neill HC
    Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell-derived exosomes as cell-free peptide-based vaccines.
    Taïeb J; Chaput N; Zitvogel L
    Crit Rev Immunol; 2005; 25(3):215-23. PubMed ID: 16048436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: the application of dendritic cell-derived exosomes in tumour immunotherapy.
    Quah B; O'Neill HC
    Cancer Biother Radiopharm; 2000 Apr; 15(2):185-94. PubMed ID: 10803324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of exosomes in immunotherapy.
    Chaput N; Taïeb J; André F; Zitvogel L
    Expert Opin Biol Ther; 2005 Jun; 5(6):737-47. PubMed ID: 15952905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.
    Zitvogel L; Regnault A; Lozier A; Wolfers J; Flament C; Tenza D; Ricciardi-Castagnoli P; Raposo G; Amigorena S
    Nat Med; 1998 May; 4(5):594-600. PubMed ID: 9585234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.
    Théry C; Regnault A; Garin J; Wolfers J; Zitvogel L; Ricciardi-Castagnoli P; Raposo G; Amigorena S
    J Cell Biol; 1999 Nov; 147(3):599-610. PubMed ID: 10545503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes.
    Théry C; Duban L; Segura E; Véron P; Lantz O; Amigorena S
    Nat Immunol; 2002 Dec; 3(12):1156-62. PubMed ID: 12426563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
    Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses.
    Segura E; Amigorena S; Théry C
    Blood Cells Mol Dis; 2005; 35(2):89-93. PubMed ID: 15990342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exosomes and anti-tumour immunotherapy].
    Chaput N; Andre F; Schartz NE; Flament C; Angevin E; Escudier B; Zitvogel L
    Bull Cancer; 2003; 90(8-9):695-8. PubMed ID: 14609758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle.
    Yan W; Jiang S
    Trends Cancer; 2020 Jun; 6(6):506-517. PubMed ID: 32460004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanovesicular vaccines: exosomes.
    Li X; Zhang Z; Beiter T; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):329-35. PubMed ID: 16088317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.
    Wolfers J; Lozier A; Raposo G; Regnault A; Théry C; Masurier C; Flament C; Pouzieux S; Faure F; Tursz T; Angevin E; Amigorena S; Zitvogel L
    Nat Med; 2001 Mar; 7(3):297-303. PubMed ID: 11231627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
    Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
    J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 458.